Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Power Life Sciences

Status: Not yet enrolling

Conditions: Hepatic Encephalopathy

Study type: Observational

Funder types: Industry

Identifiers

NCT06201988

67278255

Details and patient eligibility

About

This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in hepatic encephalopathy clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors.

In essence, this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed Written Informed Consent
• Aged ≥ 18 years old
• No prior treatment for hepatic encephalopathy

Exclusion criteria

• Participant is actively receiving study therapy in another
• Inability to provide written informed consent
• Women of childbearing potential without a negative pregnancy test; or women who are lactating.

Trial design